Middle East & Africa Bioanalytical Testing Services Market Size & Outlook
Middle East & Africa bioanalytical testing services market, 2018-2030 (US$M)
Related Markets
MEA bioanalytical testing services market highlights
- The MEA bioanalytical testing services market generated a revenue of USD 200.5 million in 2023.
- The market is expected to grow at a CAGR of 8.2% from 2024 to 2030.
- In terms of segment, small molecule was the largest revenue generating molecule in 2023.
- Large Molecule is the most lucrative molecule segment registering the fastest growth during the forecast period.
- Country-wise, South Africa is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 200.5 million |
| Market revenue in 2030 | USD 347.0 million |
| Growth rate | 8.2% (CAGR from 2023 to 2030) |
| Largest segment | Small molecule |
| Fastest growing segment | Large Molecule |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule, Large Molecule |
| Key market players worldwide | Thermo Fisher Scientific Inc, Icon PLC, Charles River Laboratories International Inc, Labcorp Holdings Inc, IQVIA Holdings Inc, Syneos Health, SGS AG, Intertek Group PLC, Pace Analytical Services |
Other key industry trends
- In terms of revenue, MEA region accounted for 4.6% of the global bioanalytical testing services market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,251.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Bioanalytical Testing Services Market Scope
Bioanalytical Testing Services Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa bioanalytical testing services market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bioanalytical testing services market will help companies and investors design strategic landscapes.
Small molecule was the largest segment with a revenue share of 55.16% in 2023. Horizon Databook has segmented the Middle East & Africa bioanalytical testing services market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.
Middle Eastern countries such as Saudi Arabia, the United Arab Emirates (UAE), Kuwait, and Oman are prospering economies. The bioanalytical testing services market in the MEA region is likely to grow steadily in the coming years.
Increasing privatization is the major factor contributing to the growth of the market. The initiatives of the government to improve the healthcare system in the region also fuel market growth.
However, the underdeveloped health infrastructure in the country may hamper the market growth in the forecasted period. For instance, the WHO International Clinical Trials Registry Platform (ICTRP) reports 861 clinical trials as registered in Africa in 2022.
Reasons to subscribe to Middle East & Africa bioanalytical testing services market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa bioanalytical testing services market databook
-
Our clientele includes a mix of bioanalytical testing services market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa bioanalytical testing services market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA bioanalytical testing services market size, by country, 2018-2030 (US$M)
Middle East & Africa Bioanalytical Testing Services Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
